Reservoir Neuroscience is focused on developing innovative therapeutics aimed at healing the blood-brain barrier (BBB), a critical structure that protects the brain from harmful substances while allowing essential nutrients to pass through. The company is pioneering approaches that target the restoration and enhancement of the BBB's integrity, which is vital for treating various neurological disorders. By addressing the challenges associated with BBB dysfunction, Reservoir Neuroscience aims to improve drug delivery to the brain and enhance the efficacy of treatments for conditions such as Alzheimer's disease, multiple sclerosis, and other neurodegenerative disorders.

The company's pipeline includes a range of products that leverage advanced scientific insights into the mechanisms governing the blood-brain barrier. Reservoir Neuroscience employs cutting-edge research methodologies to develop its therapeutics, focusing on both the biological and chemical aspects of BBB repair. This approach not only aims to restore the barrier's protective functions but also seeks to facilitate the passage of therapeutic agents into the central nervous system, thereby opening new avenues for effective treatment strategies in neurology.

United States

Reservoir Neuroscience is a biopharma company that develops novel therapeutics to treat brain disease and heal the blood-brain barrier. They are focused on developing treatments that can restore health to the aging brain and have received financing from investors such as Kizoo Technology Capital, Felicis, Healthspan Capital, R42 Group, and The Longevity Fund.

Reservoir Neuroscience

Company Details